Background:Ossification of the posterior longitudinal ligament(OPLL)is a prevalent condition in orthopedics.While death-associated protein kinase 2(DAPK2)is known to play roles in cellular apoptosis and autophagy,its ...Background:Ossification of the posterior longitudinal ligament(OPLL)is a prevalent condition in orthopedics.While death-associated protein kinase 2(DAPK2)is known to play roles in cellular apoptosis and autophagy,its specific contributions to the advancement of OPLL are not well understood.Methods:Ligament fibroblasts were harvested from patients diagnosed with OPLL.Techniques such as real-time reverse transcriptasepolymerase chain reaction(RT-qPCR)and Western blot analysis were employed to assess DAPK2 levels in both ligament tissues and cultured fibroblasts.The extent of osteogenic differentiation in these cells was evaluated using an alizarin red S(ARS)staining.Additionally,the expression of ossification markers and autophagy markers was quantified.The autophagic activity was further analyzed through LC3 immunofluorescence and transmission electron microscopy(TEM).An in vivo heterotopic bone formation assay was conducted in mice to assess the role of DAPK2 in ossification.Results:Elevated DAPK2 expression was confirmed in both OPLL patient tissues and derived fibroblasts,in contrast to non-OPLL controls.Silencing of DAPK2 significantly curtailed osteogenic differentiation and autophagy in these fibroblasts,evidenced by decreased levels of LC3,and Beclin1,and reduced autophagosome formation.Additionally,DAPK2 was found to inhibit the mechanistic target of the rapamycin complex 1(mTORC1)complex’s activity.In vivo studies demonstrated that DAPK2 facilitates ossification,and this effect could be counteracted by the mTORC1 inhibitor rapamycin.Conclusion:DAPK2 enhances autophagy and osteogenic processes in OPLL through modulation of the mTORC1 pathway.展开更多
目的:探讨死亡相关蛋白激酶(death-associated protein kinase,DAPK)基因高甲基化与胃癌的发生以及临床病理特征之间的联系。方法:采用甲基化特异性聚合酶链反应(methylation-specific PCR,MSP)法分别检测66例胃癌患者的肿瘤组织、癌旁...目的:探讨死亡相关蛋白激酶(death-associated protein kinase,DAPK)基因高甲基化与胃癌的发生以及临床病理特征之间的联系。方法:采用甲基化特异性聚合酶链反应(methylation-specific PCR,MSP)法分别检测66例胃癌患者的肿瘤组织、癌旁正常组织、手术前外周血浆以及37例术后血浆中DAPK基因启动子的甲基化状况,以20例健康人的外周血浆和胃镜活检正常胃组织作为对照。结果:胃癌组织中有66.7%(44/66)存在DAPK基因的异常甲基化,显著高于相应的癌旁正常组织[10.6%(7/66)],差异有统计学意义(P<0.001)。术前外周血浆中DAPK基因甲基化阳性率为16.7%(11/66);37例同时有胃癌根治术前后血浆标本的患者中,5例术前血浆甲基化阳性,术后全部转阴。而20例健康人的外周血浆和胃镜活检组织中均未检测到该基因甲基化。结论:DAPK基因在胃癌患者肿瘤组织和外周血浆中的高甲基化可能为胃癌的诊断以及临床预后评估提供有益的线索,手术后血浆中DAPK甲基化状态的变化可能与手术治疗有关。展开更多
基金This research received funding from the Natural Science Foundation of Shanghai(Grant No.20ZR1457600)the School-Level Basic Medical Project of Naval Medical University(Grant No.2021MS13).
文摘Background:Ossification of the posterior longitudinal ligament(OPLL)is a prevalent condition in orthopedics.While death-associated protein kinase 2(DAPK2)is known to play roles in cellular apoptosis and autophagy,its specific contributions to the advancement of OPLL are not well understood.Methods:Ligament fibroblasts were harvested from patients diagnosed with OPLL.Techniques such as real-time reverse transcriptasepolymerase chain reaction(RT-qPCR)and Western blot analysis were employed to assess DAPK2 levels in both ligament tissues and cultured fibroblasts.The extent of osteogenic differentiation in these cells was evaluated using an alizarin red S(ARS)staining.Additionally,the expression of ossification markers and autophagy markers was quantified.The autophagic activity was further analyzed through LC3 immunofluorescence and transmission electron microscopy(TEM).An in vivo heterotopic bone formation assay was conducted in mice to assess the role of DAPK2 in ossification.Results:Elevated DAPK2 expression was confirmed in both OPLL patient tissues and derived fibroblasts,in contrast to non-OPLL controls.Silencing of DAPK2 significantly curtailed osteogenic differentiation and autophagy in these fibroblasts,evidenced by decreased levels of LC3,and Beclin1,and reduced autophagosome formation.Additionally,DAPK2 was found to inhibit the mechanistic target of the rapamycin complex 1(mTORC1)complex’s activity.In vivo studies demonstrated that DAPK2 facilitates ossification,and this effect could be counteracted by the mTORC1 inhibitor rapamycin.Conclusion:DAPK2 enhances autophagy and osteogenic processes in OPLL through modulation of the mTORC1 pathway.
文摘目的:探讨死亡相关蛋白激酶(death-associated protein kinase,DAPK)基因高甲基化与胃癌的发生以及临床病理特征之间的联系。方法:采用甲基化特异性聚合酶链反应(methylation-specific PCR,MSP)法分别检测66例胃癌患者的肿瘤组织、癌旁正常组织、手术前外周血浆以及37例术后血浆中DAPK基因启动子的甲基化状况,以20例健康人的外周血浆和胃镜活检正常胃组织作为对照。结果:胃癌组织中有66.7%(44/66)存在DAPK基因的异常甲基化,显著高于相应的癌旁正常组织[10.6%(7/66)],差异有统计学意义(P<0.001)。术前外周血浆中DAPK基因甲基化阳性率为16.7%(11/66);37例同时有胃癌根治术前后血浆标本的患者中,5例术前血浆甲基化阳性,术后全部转阴。而20例健康人的外周血浆和胃镜活检组织中均未检测到该基因甲基化。结论:DAPK基因在胃癌患者肿瘤组织和外周血浆中的高甲基化可能为胃癌的诊断以及临床预后评估提供有益的线索,手术后血浆中DAPK甲基化状态的变化可能与手术治疗有关。
